两例儿童SARS-CoV-2疫苗接种后多系统炎症综合征
本报告呈现2例儿童在接种首剂且唯一一剂辉瑞-BioNTech SARS-CoV-2疫苗后6周内发生多系统炎症综合征(MIS-V)的病例。例1表现为伴心包心肌炎和休克的MIS-C/A,例2具有典型川崎病特征;两者对静脉免疫球蛋白和/或全身皮质类固醇反应良好,且仅抗S抗体阳性而抗NC抗体阴性,提示为疫苗接种后而非感染后事件。
要点
- 两例儿童在接种首剂辉瑞-BioNTech疫苗后6周内发生MIS-V。
- 例1伴心包心肌炎和休克,例2呈典型川崎病特征。
- 两者对IVIG和/或全身皮质类固醇反应良好。
核心结论
- 两例儿童在接种SARS-CoV-2疫苗后发生MIS-V,仅抗S抗体阳性而抗NC抗体阴性,提示为疫苗接种后事件而非感染后事件。
研究设计与样本
- 病例报告,描述2例儿童在接种首剂且唯一一剂辉瑞-BioNTech SARS-CoV-2疫苗后发生MIS-V的临床过程。
主要发现
- 两例均在接种首剂且唯一一剂辉瑞-BioNTech疫苗后6周内出现MIS-V。
- 例1表现为伴心包心肌炎和休克的MIS-C/A,例2具有典型川崎病特征。
- 两例均对静脉免疫球蛋白和/或全身皮质类固醇反应良好。
- 两例仅抗SARS-2-CoV刺突(S)抗体阳性、抗核衣壳(NC)抗体阴性,符合疫苗接种后而非感染后事件。
- 两例患者未再接种任何其他SARS-CoV-2疫苗。
关键数值与推荐
- 在特定时间窗内检测抗S和抗NC抗体有助于区分MIS-V(仅抗S阳性)与SARS-CoV-2感染后MIS-C/A(抗S和抗NC均阳性)。
临床怎么用
- 对SARS-CoV-2疫苗接种后6周内出现多系统炎症表现的儿童,应考虑MIS-V可能。
- 检测抗S和抗NC抗体有助于鉴别MIS-V与感染后MIS-C/A。
- MIS-V治疗可参照MIS-C/A使用静脉免疫球蛋白和/或全身皮质类固醇。
- 在5至11岁年龄组(SARS-CoV-2感染后MIS-C风险最高)获批接种后,应继续监测免疫接种后罕见不良事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This report presents 2 pediatric cases of multisystem inflammatory syndrome in children and adults (MIS-C/A) post severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination (MIS-V). Both children presented with MIS-V within 6 weeks of receiving their first and only dose of Pfizer-BioNTech's SARS-CoV-2 vaccine. The first patient had symptoms of MIS-C/A with peri-myocarditis and shock, and the second 1 had classic Kawasaki disease features. Both responded well to intravenous immunoglobulins and/or systemic corticosteroids. Both children were positive only for SARS-2-CoV antispike (S) (and not for antinucleocapsid [NC]) antibodies consistent with a postvaccine, and not a postinfection, event. Surveillance for rare adverse events following immunization should continue, especially now that SARS-CoV-2 vaccination is approved in the 5 to 11 year age group that has had the highest risk of developing MIS-C post SARS-CoV-2 infection. Our patients did not receive any further SARS-CoV-2 vaccines. Our report highlights the importance of measuring differentiating antibodies (anti-S and anti-NC) that can be used within a specific timeframe to help determine if a patient has MIS-V post vaccine (only anti-S present), or MIS-C/A post SARS-CoV-2 infection (both anti-S and anti-NC present).
引用
- Karatzios C, Scuccimarri R, Chédeville G, et al. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Vaccination in Two Children. Pediatrics. 2022. PMID: 35614536. doi:10.1542/peds.2021-055956
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。